Over RMB 1 Billion Already Invested In Roche's "China Experiment"
This article was originally published in PharmAsia News
Executive SummaryFrom early drug discovery to late-stage clinical development and product registration, Roche has invested over RMB 1 billion to construct a comprehensive drug development chain in China
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.